Proteomic analysis of circulating human monocytes in coronary artery disease

Aruna Poduri1, Ajay Bahl, Kewal K Talwar

  • 1Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Insights

Proteomic analysis of monocytes reveals key protein expression changes in coronary artery disease (CAD). This study identified specific proteins altered in CAD patients, offering new insights into atherosclerosis pathogenesis.

Area of Science:

  • Cardiovascular Biology
  • Proteomics
  • Immunology

Background:

  • Monocytes are crucial in inflammation and atherosclerosis, but their molecular functions in coronary artery disease (CAD) require further elucidation.
  • Understanding monocyte behavior is vital for advancing CAD research and treatment strategies.

Purpose of the Study:

  • To investigate the proteomic profile of monocytes in patients with coronary artery disease (CAD).
  • To identify differentially expressed proteins in monocytes that may contribute to the pathogenesis of atherosclerosis.

Main Methods:

  • Proteomic analysis using 2D gel electrophoresis and mass spectrometry on circulating monocytes from CAD patients and healthy controls.
  • Comparison of protein spot intensity between the CAD group (n=20) and control group (n=20).

Main Results:

  • Identified 63 differentially expressed protein spots in monocytes from CAD patients compared to controls.
  • Found decreased expression of glutathione transferase and heat shock protein 70 KDa.
  • Observed increased expression of vimentin, mannose binding lectin receptor protein, and S100A8 calcium-binding protein in CAD patients.

Conclusions:

  • The study identified specific proteins (vimentin, mannose binding lectin receptor, S100A8, glutathione transferase, HSP70) with altered expression in monocytes of CAD patients.
  • These findings provide novel molecular insights into the role of monocytes in atherosclerosis development.
  • The identified proteins may serve as potential biomarkers or therapeutic targets for CAD.